Sonia Brugnara Mariacristina Sicher Elena Maria Bonandini Mattia Barbareschi Carlo Renè Girardelli Orazio Caffo
10.7573/dic.212582
Drugs Context
2019 Dec 18;8:212582.
braf mek v600e mutation immune system activation melanoma targeted therapy vitiligo
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/32158480/
Case Reports
PMC7048152
32158480
Onset of vitiligo following targeted therapy for BRAFV600E-mutated melanoma: case report
2019